NGIO could have been listed last year had Joe continued with buying the shell company, which is common this year by all the big boys and girls. We could have reverse merged into them (NGIO that is) and been trading. However Joe probably would have had to give up 20% of NGIO to the shell company. Would that have been good? I'd say so since Covid hit and NGIO would have been a known, hot commodity at that point. GNBT would have had all the money they needed too. I said back then, definitely use the shell company. They never even told us they decided against using the shell. They started filing S1s and we had to ask. Then he admitted they decided not to go that route, when they already had a deal made on the shell. Bad decisions being made...too often.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.